Study Details

Back
Study ID 8477-CL-0020
Study Title A Phase 2a Enriched Enrollment Randomized Withdrawal Study to Assess Analgesic Efficacy and Safety of ASP8477 in Subjects with Peripheral Neuropathic Pain
Clinicaltrials.gov Identifier NCT02065349
Compound Name ASP8477
Medical Indication or Disease Peripheral neuropathy
Study Sponsor Astellas Pharma B.V.
Collaborator Not Applicable
Study Start Date 24-Feb-2014
Study Completion Date 13-Feb-2015
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS